Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/14/25 16:04 | 11/12/25 | AGIO | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | 6 | M.d | 36 | 29.85 | 0 | 1 | 7 | 18 | D | |||||||||||||||
11/14/25 16:04 | 11/12/25 | AGIO | Health | Drug | Pharmaceutical Preparations | Scadden David | MA | D | 6 | S.d | -36 | 29.85 | 0 | -1 | 18 | D | ||||||||||||||||
11/13/25 16:08 | 10/30/25 | AGIO | Health | Drug | Pharmaceutical Preparations | Gheuens Sarah | MA | O | Chief Me | 6 | M.d | 410 | 34.43 | 0 | 12 | 24 | 62 | D | ||||||||||||||
11/13/25 16:08 | 10/30/25 | AGIO | Health | Drug | Pharmaceutical Preparations | Gheuens Sarah | MA | O | Chief Me | 6 | S.d | -410 | 34.43 | 0 | -12 | 62 | D | |||||||||||||||
9/30/25 17:56 | 9/26/25 | AGIO | Health | Drug | Pharmaceutical Preparations | Jones Cecilia | MA | O | CFO | 2 | M.d | 134 | 12.07 | 0 | 11 | 49 | 34 | D | ||||||||||||||
9/30/25 17:56 | 9/26/25 | AGIO | Health | Drug | Pharmaceutical Preparations | Jones Cecilia | MA | O | CFO | 2 | S.d | -134 | 12.07 | 0 | -11 | 34 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |